Collier v. Bayer HealthCare Pharmaceuticals Inc.

D. Minnesota

Collier v. Bayer HealthCare Pharmaceuticals Inc.

DecidedJuly 9, 2018

Docket0:18-cv-01897

StatusUnknown

This text of Collier v. Bayer HealthCare Pharmaceuticals Inc. (Collier v. Bayer HealthCare Pharmaceuticals Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Collier v. Bayer HealthCare Pharmaceuticals Inc., (mnd 2018).

Pincite

Opinion

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION

IN RE: FLUOROQUINOLONE PRODUCTS LIABILITY LITIGATION MDL No. 2642

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO —128)

On August 17, 2015, the Panel transferred 19 civil action(s) to the United States District Court for the District of Minnesota for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 122 F.Supp.3d 1378 (J.P.M.L. 2015). Since that time, 749 additional action(s) have been transferred to the District of Minnesota. With the consent of that court, all such actions have been assigned to the Honorable John R. Tunheim. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the District of Minnesota and assigned to Judge Tunheim. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the District of Minnesota for the reasons stated in the order of August 17, 2015, and, with the consent of that court, assigned to the Honorable John R. Tunheim. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the District of Minnesota. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this 7-day period, the stay will be continued until further order of the Panel.

Inasmuch as no objection is pending at this time, the stay is ied. FOR THE PANEL: CMniteo ares Jeffery N. Ltithi Atrue printed copyin 2 sheet{s) Clerk of the Panel of the electronic record filed on 7/6/18 . in the United States District Court for the District of Minnesota. CERTIFIED, July 09 2018 Vgicre Kate M. Fogarty, Clerk Pern ov Nast st onan oO Mallia? AS / Tran.ekiur Clael

IN RE: FLUOROQUINOLONE PRODUCTS LIABILITY LITIGATION MDL No. 2642

SCHEDULE CTO-128 — TAG-ALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

CALIFORNIA NORTHERN CAN 4 18-02617 Collier v. Bayer HealthCare Pharmaceuticals Inc. et al IZ ev □□□□

Free access — add to your briefcase to read the full text and ask questions with AI

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION

IN RE: FLUOROQUINOLONE PRODUCTS LIABILITY LITIGATION MDL No. 2642

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO —128)

On August 17, 2015, the Panel transferred 19 civil action(s) to the United States District Court for the District of Minnesota for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 122 F.Supp.3d 1378 (J.P.M.L. 2015). Since that time, 749 additional action(s) have been transferred to the District of Minnesota. With the consent of that court, all such actions have been assigned to the Honorable John R. Tunheim. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the District of Minnesota and assigned to Judge Tunheim. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the District of Minnesota for the reasons stated in the order of August 17, 2015, and, with the consent of that court, assigned to the Honorable John R. Tunheim. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the District of Minnesota. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this 7-day period, the stay will be continued until further order of the Panel.

Inasmuch as no objection is pending at this time, the stay is ied. FOR THE PANEL: CMniteo ares Jeffery N. Ltithi Atrue printed copyin 2 sheet{s) Clerk of the Panel of the electronic record filed on 7/6/18 . in the United States District Court for the District of Minnesota. CERTIFIED, July 09 2018 Vgicre Kate M. Fogarty, Clerk Pern ov Nast st onan oO Mallia? AS / Tran.ekiur Clael

IN RE: FLUOROQUINOLONE PRODUCTS LIABILITY LITIGATION MDL No. 2642

SCHEDULE CTO-128 — TAG-ALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

CALIFORNIA NORTHERN CAN 4 18-02617 Collier v. Bayer HealthCare Pharmaceuticals Inc. et al IZ ev □□□□

Cite This Page — Counsel Stack

Bluebook (online)

Collier v. Bayer HealthCare Pharmaceuticals Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/collier-v-bayer-healthcare-pharmaceuticals-inc-mnd-2018.

Opinion

Related

Cite This Page — Counsel Stack